Accuray Incorporated (ARAY)

Market Cap	16.36M -91.4%
Revenue (ttm)	401.95M -12.3%
Net Income	-49.19M
EPS	-0.40
Shares Out	119.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,525,143
Open	0.1490
Previous Close	0.1420
Day's Range	0.1334 - 0.1528
52-Week Range	0.1334 - 1.6900
Beta	1.42
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2026

About ARAY

Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidn...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 8, 2007
• Employees: 809
• Stock Exchange: Nasdaq
• Ticker Symbol: ARAY
• Website: https://www.accuray.com

Financial Performance

In fiscal year 2026, Accuray's revenue was $401.95 million, a decrease of -12.34% compared to the previous year's $458.51 million. Losses were -$49.19 million, 2992.0% more than in 2025.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 22, 2026

Data Sources Report a data error